The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model
Shares:
It’s a big 340B day, starting with a decision by a federal appeals court to side with Arkansas in a dispute with PhRMA. Arkansas has a law that says that
I know there are some new readers today, and, in the interest of expectation-setting, I wanted to reassure them that the newsletter isn’t usually this long. But I’ve been thinking
Full disclosure: I’m not sure about the publication schedule for the rest of the week. It’s election day here in the United States. I haven’t written much about the election